Injection Regimen Trial of PEG-rhG-CSF During Breast Cancer Chemotherapy
NCT04477616
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
160
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Day 7 regimen
DRUG:
Day 3 regimen
Sponsor
The First Affiliated Hospital with Nanjing Medical University